NO761101L - - Google Patents
Info
- Publication number
- NO761101L NO761101L NO761101A NO761101A NO761101L NO 761101 L NO761101 L NO 761101L NO 761101 A NO761101 A NO 761101A NO 761101 A NO761101 A NO 761101A NO 761101 L NO761101 L NO 761101L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- preparation according
- carrier component
- colon
- salts
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 claims abstract description 21
- 210000001072 colon Anatomy 0.000 claims abstract description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 239000000126 substance Substances 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 9
- 229920002125 Sokalan® Polymers 0.000 claims description 8
- 208000002551 irritable bowel syndrome Diseases 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 230000008961 swelling Effects 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000001913 cellulose Substances 0.000 claims description 6
- 235000010980 cellulose Nutrition 0.000 claims description 6
- 229920002678 cellulose Polymers 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 239000004584 polyacrylic acid Substances 0.000 claims description 6
- 239000011230 binding agent Substances 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 238000010521 absorption reaction Methods 0.000 claims description 4
- 235000010410 calcium alginate Nutrition 0.000 claims description 4
- 239000000648 calcium alginate Substances 0.000 claims description 4
- 229960002681 calcium alginate Drugs 0.000 claims description 4
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- 244000215068 Acacia senegal Species 0.000 claims description 3
- 229920000084 Gum arabic Polymers 0.000 claims description 3
- 229920000148 Polycarbophil calcium Polymers 0.000 claims description 3
- 235000010489 acacia gum Nutrition 0.000 claims description 3
- 239000000205 acacia gum Substances 0.000 claims description 3
- 229950005134 polycarbophil Drugs 0.000 claims description 3
- 244000106483 Anogeissus latifolia Species 0.000 claims description 2
- 235000011514 Anogeissus latifolia Nutrition 0.000 claims description 2
- 239000001922 Gum ghatti Substances 0.000 claims description 2
- 235000019314 gum ghatti Nutrition 0.000 claims description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims 2
- 239000006096 absorbing agent Substances 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 235000002639 sodium chloride Nutrition 0.000 claims 1
- 206010013554 Diverticulum Diseases 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 206010013530 Diverticula Diseases 0.000 description 4
- 208000012258 Diverticular disease Diseases 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- -1 fibres Polymers 0.000 description 3
- 210000004051 gastric juice Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000037023 motor activity Effects 0.000 description 3
- 230000001148 spastic effect Effects 0.000 description 3
- 235000015099 wheat brans Nutrition 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 235000010451 Plantago psyllium Nutrition 0.000 description 2
- 244000090599 Plantago psyllium Species 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000007784 diverticulitis Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 description 2
- 229920002689 polyvinyl acetate Polymers 0.000 description 2
- 239000011118 polyvinyl acetate Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001078 anti-cholinergic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 239000003979 granulating agent Substances 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7504049A SE7504049L (sv) | 1975-04-09 | 1975-04-09 | Colonpreparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO761101L true NO761101L (xx) | 1976-10-12 |
Family
ID=20324216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO761101A NO761101L (xx) | 1975-04-09 | 1976-03-30 |
Country Status (12)
| Country | Link |
|---|---|
| BE (1) | BE840552A (xx) |
| DE (1) | DE2614296A1 (xx) |
| DK (1) | DK153376A (xx) |
| FI (1) | FI56772C (xx) |
| FR (1) | FR2306710A1 (xx) |
| GB (1) | GB1538123A (xx) |
| IE (1) | IE42793B1 (xx) |
| LU (1) | LU74732A1 (xx) |
| NL (1) | NL7603600A (xx) |
| NO (1) | NO761101L (xx) |
| NZ (1) | NZ180552A (xx) |
| SE (1) | SE7504049L (xx) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS52139715A (en) * | 1976-05-14 | 1977-11-21 | Nippon Kayaku Co Ltd | Coated granules of alkali polyacrylate |
| FR2471186A1 (fr) * | 1979-12-10 | 1981-06-19 | Roussel Uclaf | Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation |
| US4444761A (en) * | 1981-05-04 | 1984-04-24 | Syntex (U.S.A.) Inc. | Cellulose/carboxymethyl cellulose mixtures useful for controlling fecal output, and methods employing them |
| US4522804A (en) * | 1983-01-03 | 1985-06-11 | Verex Laboratories, Inc. | Constant release rate solid oral dosage formulations of propranolol |
| US4461759A (en) * | 1983-01-03 | 1984-07-24 | Verex Laboratories, Inc. | Constant release rate solid oral dosage formulations of veropamil |
| US4521401A (en) * | 1983-01-03 | 1985-06-04 | Verex Laboratories, Inc. | Constant release rate solid oral dosage formulations of quinidine |
| DE3776116D1 (de) * | 1986-12-30 | 1992-02-27 | American Cyanamid Co | Zusammensetzung die ein polycarbophil enthaelt. |
| GB8817015D0 (en) * | 1988-07-16 | 1988-08-17 | Reckitt & Colmann Prod Ltd | Method of treatment |
| FR2636532B1 (fr) * | 1988-09-20 | 1993-11-19 | Glaxo Group Ltd | Compositions pharmaceutiques |
| IL98087A (en) * | 1990-05-04 | 1996-11-14 | Perio Prod Ltd | Preparation for dispensing drugs in the colon |
| HU210497B (en) * | 1990-05-04 | 1995-04-28 | Perio Prod Ltd | Process for production of modified pectin |
| DE9212938U1 (xx) * | 1992-09-25 | 1992-11-26 | Boehringer Ingelheim Gmbh, 6507 Ingelheim, De | |
| US5840332A (en) * | 1996-01-18 | 1998-11-24 | Perio Products Ltd. | Gastrointestinal drug delivery system |
| MX2019012086A (es) | 2017-04-14 | 2021-01-08 | Gelesis Llc | Composiciones y métodos para tratar o prevenir trastornos relacionados con la permeabilidad intestinal. |
-
1975
- 1975-04-09 SE SE7504049A patent/SE7504049L/xx unknown
-
1976
- 1976-03-30 NO NO761101A patent/NO761101L/no unknown
- 1976-03-31 DK DK153376A patent/DK153376A/da not_active IP Right Cessation
- 1976-04-02 DE DE19762614296 patent/DE2614296A1/de not_active Withdrawn
- 1976-04-06 NL NL7603600A patent/NL7603600A/xx not_active Application Discontinuation
- 1976-04-07 FI FI760948A patent/FI56772C/fi not_active IP Right Cessation
- 1976-04-08 NZ NZ180552A patent/NZ180552A/xx unknown
- 1976-04-08 FR FR7610342A patent/FR2306710A1/fr active Granted
- 1976-04-08 GB GB14390/76A patent/GB1538123A/en not_active Expired
- 1976-04-09 LU LU74732A patent/LU74732A1/xx unknown
- 1976-04-09 BE BE165981A patent/BE840552A/xx unknown
- 1976-04-09 IE IE749/76A patent/IE42793B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE2614296A1 (de) | 1976-10-21 |
| FI760948A (xx) | 1976-10-10 |
| NL7603600A (nl) | 1976-10-12 |
| BE840552A (fr) | 1976-10-11 |
| IE42793L (en) | 1976-10-09 |
| NZ180552A (en) | 1978-07-28 |
| GB1538123A (en) | 1979-01-10 |
| FI56772C (fi) | 1980-04-10 |
| IE42793B1 (en) | 1980-10-22 |
| SE7504049L (sv) | 1976-10-10 |
| FR2306710A1 (fr) | 1976-11-05 |
| FI56772B (fi) | 1979-12-31 |
| FR2306710B1 (xx) | 1979-07-13 |
| LU74732A1 (xx) | 1977-02-04 |
| DK153376A (da) | 1976-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO761101L (xx) | ||
| AU2013258566B2 (en) | Pyrazole derivative and use thereof for medical purposes | |
| US5840756A (en) | Pharmaceutical composition of L-DOPA ester | |
| JPH045647B2 (xx) | ||
| WO1998022105A1 (fr) | Preparation en comprimes | |
| WO1984000104A1 (en) | Sustained release propranolol tablet | |
| WO2015081887A1 (zh) | 一种酸性蒙脱石氢氧化钙药物组合物及制备、产品和应用 | |
| KR100479968B1 (ko) | 위장 리파아제 억제제의 용도 | |
| WO2022193723A1 (zh) | 一种组合物及其制备方法和用途 | |
| FR2904774A1 (fr) | Composition pharmaceutique solide contenant une combinaison d'un agent regulateur de la motilite intestinale et d'un antiflatulent. | |
| KR20210042042A (ko) | 페놀라민 g형 결정, 제조 방법과 그의 조성물 및 용도 | |
| CN115804802B (zh) | 泽漆挥发油在治疗细菌性肠炎疾病药物中的应用 | |
| CN101590031B (zh) | 磺化去氢松香酸二钠组合物的制备方法 | |
| US3211615A (en) | Oral antidiabetic composition and method of use | |
| CN101491493A (zh) | 阿魏酸哌嗪缓释药物制剂 | |
| JPS62207212A (ja) | 抗アレルギ−剤 | |
| JP2005524604A (ja) | 活性炭を含有する経口製剤及びその用途 | |
| JP4022300B2 (ja) | 下剤組成物 | |
| Krishnaswamy et al. | Mental changes and platelet serotonin in pellagrins | |
| Marks | Cellulose esters in the treatment of constipation | |
| KR102078433B1 (ko) | 변비증의 예방 또는 치료약 | |
| CN101406496A (zh) | 一种治疗前列腺炎及其它男性生殖系统疾病的配方 | |
| CN1121221C (zh) | 含有糖精亚铁的药物制剂 | |
| Block | Management of constipation with a refined psyllium combined with dextrose | |
| CN101757007A (zh) | 一种二甲双胍/阿卡波糖降糖口服制剂组合物及其制备 |